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Vitamin K-dependent carboxylase is demonstrated in skin 
microsomes from humans, rats, rabbits, and mice. This 
erizyme converts a number of distinct protein-bound glu-
tamic acid residues ii1to y-carboxyglutamic acid residues, 
which strongly interact with Ca + + ions. The enzymatic 
activity (expressed per mg protein) in skin is about 29% 
of that in liver. Vitamin K-dependent carboxylase is present 
in both epidermal and dermal tissue. It is demonstrated 
that warfarin treatm.ent in mice results in an accumulation 
V· itamin K is involved in a posttranslational modifi-cation of proteins [1,2). T his modification consists of the carboxylation of a number of distinct glutamic acid residues into y-carboxyglutamic acid residues (Gla). The presence of Gla has initially been discov-
ered in blood coagulation factors, which are synthesized in the 
liver [3,4). The Gla-rich regions are essential for the proper func-
tioning of these coaguiation factors . Coumarin derivatives, such 
as warfari n, inhibit the formation of Gla residues and therefore 
they are used as anticoagulants [5). 
For a long period it has been thought that the vitamin K-
dependent carboxylation was restricted to the liver. During the 
last decade, however, similar enzyme systems have been detected 
in various other tissues such as kidney, spleen, testis, lung, and 
vessel wall [6,7] . In vivo, the administration of low doses .of 
warfarin affects both the hepatic as well as the non hepatic car-
boxylase systems [8). It is to be expected that all these vitamin 
K-dependent enzymes are involved in the production of Gla-
containing proteins, but in most cases their precise function and 
even their place of action are unknown. Gla-containing proteins 
have been demonstrated in, for instance, bone [9), renal stones 
[10], calcified atheromatous plaques [11), calCium-containing ma-
terial extruded from the skin of scleroderma patients , and .in the 
calcified skin and subcutaneous plaques from patients with der-
matomyositis [12]. Whereas it has been suggested that the bone 
Gla protein is synthesized by the osteoblasts [13], the origin of 
the Gla-containing proteins in the calcifi ed plaques occurring in 
the skin diseases mentioned above has remained obscure until 
now. It was of interest, therefore, to examine skin tissue for the 
presence of vitamin K-dependent carboxylase. The results of our 
investigations are presented in this paper. 
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CHAPS: 3-((3-cholamidopropyl)-dimethylammoniol-1-propane-
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OTT: dithiotreitol 
of non carboxylated precursor proteins in both del:mal and 
epidermal microsomes. Most probably this effect of war-
farin is not restricted to mice, but occurs also in the skin 
of patients under oral anticoagulant therapy. A possible 
relation between vitamin K-:dependent skin carboxylase and 
the y-carboxyglutamic acid-contaiiung protein in calcified 
nodules from patients with scleroderma and dermatomy-
ositis is discussed. J [nllest Dermatol 87:377-380, 1986 
MATERIALS AND METHODS 
Materials Vitamin KJ (konakion) was obtained from Hoff-
mann-La Roche (Basel, Switzerland). Vitamin K hydroquinone 
was prepared as described earlier [14]. 3-[(3-Cholamidopropyl)-
dilllethylammonio ]-1-propane sul fonate (CHAPS), dithiothreitol 
(DTT), and warfarin were ftom Sigma (St. Louis, Missouri) and 
the synthetic penta peptide Phe-Leu-Glu-Glu-Leu (F LEE L) was 
from Vega Biochemicals (Tucson, Arizona). NaH 14C03 (40-60 
Ci/mol) was purchased from Amersham (Amersham, U.K.) and 
Atomlight from N ew England Nuclear (Dreieich, F.R.G.). Dis-
pase protease neutrale from Bacillus polymixa grade II was obtained 
from Boehringer Mannheim (Mannheim, F.R.G.). All other 
chemicals were from M erck (Darmstadt, F.R.G.). Athymic, hair-
less m.ice, strain NMRI, ml/m~ were obtained from' TNO (Zeist, 
The N etherlands). 
Me~hods Skin tissue was obtained from 12- to 16-week-old 
hairless, athymic mice, newborn Lewis rats, and newborn Hol-
lander rabbits. The animals were sacrificed under ether anesthesia. 
Skin tissue from humans without known skin diseases was ob-
tained from the Departments of Pathology in hospitals at Maas-
tricht and Amsterdam. All pieces of skin tissue were obtained less 
than 3 h after death and they were immediately frozen at - BO°C. 
For some experiments, livers, kidneys, lungs, and testes were 
excised from athymic mice shortl y after their sacrifice. For some 
experiments these mice were injected i. p. with warfarin dissolved 
in 150 mM N aCl, pH 7.4, in a dose of 10 mg/kg body weight, 
18 h before sacrifice. 
. Epidermal tissue was separated from the underlying connective 
tissue by dispase treatment. Therefore we slightly modified the 
method described by Kitano and Okada [15). Skin tissue was cut 
into pieces of about 2 X 4 cm and incubated at room temperature 
with 150 ml 0.5% dispase (w/v), 0.15 M NaCI pH 7.4, during 
4-6 h. After this incubation th~ skin could be divided into epi-
dermis and dermis with a small spatula. To control the separation, 
pieces of tissue were fixed in phosphate-buffered formalin and 
embedded in paraffin. Four-micrometer tissue; sections were stained 
with hematoxylin or azan and examined with a light microscope. 
The microsomal fractions of the tissues were prepared in a 
similar way as described earlier [6]. After 3 washing cycles the 
microsomes were suspended in buffer A [0.1 M NaCl, 0.05 M 
Tris-HCl, pH 7.5,1 mM EDTA, 20% (v/v) ethyleneglycol] to a 
concentration of 3-10 mg protein/ml and stored at - 80°C. 
The carboxylase activity was measured by incubating 0.25 ml 
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of reaction mixtures at 25°C iIi buffer A, containing 0.4 mg mi-
crosomal protein, 0.1 mg CHAPS, 10 mM F LEE L, 8 mM 
DTT, 0.2 mM vitamin K hydroquinone, 0.01 mCi NaH I4COJ , 
and 1 M (NH4hS04' The reaction was stopped and non bound 
14COz was removed by adding trichloroacetic acid (5%) and de-
gassing the solution for 2 min at elevated temperatures. The sam-
ples were supplemented with 10 ml Atomlight and counted in a 
Beckman scintillation counter. Since under the incubation con-
ditions all reaction components are present in excess; the initial 
reaction rates are proportional to the respective amounts of car-
boxylase. To measure the amount of endogenous substrate no 
F LEE L was added to the reaction mixture. In all experiments 
parallel incubations were performed in the absence of vitamin K 
hydroquinone and DTT; these blank values were subtracted. It 
was ascertained that dispase had no effect on the carboxylase-
activity measurements. 
Protein concentration was determined according to Sedmak 
and Grossberg [16] . 
Gla residues were determined by alkaline hydrolysis of ho-
mogenized tissue and subsequent high-performance liquid chro-
matogr~phy analysis on a Nucleosil 5SB column (Chrompack) 
as described by Kuwada and Katayama [17] . 
RESULTS 
Dete'ction of Vitamin K-Dependent Carboxylase Ac-
tivity Skin tissue was obtained from humans, hairless mice, 
and from newborn rats and rabbits. After homogenization the 
microsomal fractions were prepared. In all these species vitamin 
K-dependent carboxylase activity could be demonstrated (Table 
I). The rather'low amounts measured in the rabbit and rat prep-
arations may be caused by a less efficient homogenization of the 
tissues. All experimen~s described below were performed with 
hairless mice as their skiri is most readily homogenized. 
To compare the amounts of vitamin K-dependent carboxylase 
activity in skin and other tissues we also prepared microsomal 
fractions of liver, kidney, spleen, and testes from the same ~ni­
mals. In all microsomal preparations carboxyIation proceeded in 
a linear way for at least 30 min. The skin .carboxylase activity is 
comparable with that in other nonhepatic tissues, but much lower 
than the liver carboxylase activity (Table U). The ratio between 
the enzyme activities in liver, kidney, spleen, lung, and testis 
microsomes from these mice is in reasonable agreement with 
results earlier found for rats [7]. 
Localization of Skin Carlloxylase In earlier experiments we 
demonstrated a considerable vitamin K-dependent carboxylase 
activity in bovine vessel wall. It cannot be excluded that this 
vascular enzyme accounts, at least partly, for the carboxylase 
activity demonstrated in microsomes derived from several whole 
tissue homogenates. Experiments were undertaken to investigate 
whether the skin carboxylase activity could be attributed to the 
vascular vitamin K-dependent carboxylase system. As the epi-
dermis does not contain any blood vessels, skin was separated 
into epidermal and dermal tissue by dispase treatment. It was 
ascertained by histologic techniques that the epidermal cells did 
Table I. Vitamin K-Dependent Carboxylase Activity in Skin 
from Various Species 
Species 
Human 
Rabbit 
Rat 
Mouse 
Carboxylase Activity 
(dpmlmin/mg protein) 
500 
105 
200 
590 
Microsomes were prepared from about 10 g of skin tissue, and carboxylase activity 
was measured as described in Malerials alld Mellrods. Blank values without added 
KH, and OTT (15-30 dpm/min/mg protein) were subtracted. The data are the mean 
of duplicate measu rements. 
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Table II. Vitarnin K-Dependent Carboxylase Activity in 
Various Tissues from Athymic Mice 
I·C02 Incorporated (dpm) 
Relative Ca rboxylase 
Tissue +KH2 - KH2-DTT Activity (%) 
Skin 6,470 245 100 
Liver 36,200 200 580 
Kidney 3,810 340 56 
Lung 12,010 220 190 
Spleen 2,720 370 38 
Testis 5,250 290 80 
The vitamin K-dcpcndcnt carboxylase activities arc given as the amount of 14CO~ 
incorporated in 25 min in the presence and absence of vitamin KH, and OTT. AU 
reaction mixtures contained 0.4 mg of microsomal protein. In the last colunll1 the 
acti vi ties are expressed as a percentage of the skin carboxylase act ivity per nlg 
microsomal protein . 
not contain any detectable amount of dermal tissue and vice versa 
(Fig 1) . Carboxylase activity was detected in both microsomal 
preparations. The carboxylation rate was constant for about 30 
min as is shown in Fig 2. 
Effects of Warfarin Treatment In Vivo In liver, warfarin 
treatment causes the accumulation of noncarboxylated precursors 
of blood coagulation factors. A part of these precursors remains 
firmly bound to the microsomal carboxylase complex and can be 
carboxylated in vitro (endogenous substrate). We investigated 
Figure 1. Skin tissue of athymic mice. A, Skin before dispase treatment, 
stained with hematoxylin. B, Epidermis, stained with hematoxylin. C, 
Dermis, stained with azan. Bar = 0.1 nm. 
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Figure 2 . Time course of vitamin K-dependent carboxylation. The car-
boxylation was performed as described in Materials alld Methods. Blank 
values without added vitamin KH2 and DTT (200-450 dpm/mcubatlOn) 
were subtracted. Solid circles, dermis microsomes; opell circles, epidermis 
microsomes. 
whether a similar effect of w arfarin would occur in skin tissue. 
Athymic mice were injected i.p. with a dose ofl0 mg warfa.rin /kg 
body weight. After 24 h the mice were sacrificed, the sk1l1 was 
removed, and the livers and kidneys were excised . Microsomes 
were prepared and the amounts of endogenous substrates were 
measured . In all preparations an increase of noncarboxylated pre-
cursor proteins was demonstrated after w arfarin treatment (Table 
III). This increase was comparable in skin and kidney, whereas 
in liver a higher level of endogenous substrate was detected. TIlls 
is in agreement with earlier results obtained from bovine and rat 
experiments in which invariably a higher accumulation of en-
dogenous substrate was found in liver than in other tissues [6-8). 
The sum of the quantities of endogenous substrate found 111 the 
m.icrosomes from isolated dermal and epidermal tissue was slightly 
lower than the amount of endogenous substrate found in total 
skin microsomes . This was due to the dispase treatment. N ever-
theless, an increase of noncarboxylated precursor proteins w~s 
demonstrated after warfarin treatment in epidermis and dermiS 
as well. To determine whether ['4C)Gla was form ed in the pre-
cursor proteins , incubated samples of microsomes from warfarin-
treated mice were heated at 110°C in 6 N HCI for 24 h. This 
treatment resulted in a loss of 59% of the bound 14C in total skin 
microsomes, 47% in dermal microsomes, 56% in epidermal mi-
crosomes, and 54% in liver microsomes . The theoretical loss o f 
14C from [ '4C)Gla labeled in one of the carboxyl groups would 
be 50% . From these results we concluded that under our exper-
imental conditions Gla residues had been form ed by skin micro-
somes. 
Presence of Vitamin K-Reductase In bovine liver and other 
nonhepatic microsomes, vitamin K-dependent carboxylase has 
Table III. Amounts of Accumulated Endogenous Substrate 
after Warfarin Treatment 
Tissue 
Liver 
Kidney 
Skin 
Dermis 
Epidermis 
Amounts of Endogenous Substrate 
(dpm/60 min/mg protein) 
After Warfarin 
Normal Treatment 
4,970 14,460 
770 1,540 
1,260 2,560 
970 2,000 
800 2,230 
Warfarin was given i.p. in a dose of 10 mg/kg body weight to 16 athymic mice. 
Microsomes were prepared from the pooled tissues of normal and warfarin-treated 
mice, respectively , and endogenous substrate was measured as described in Materials 
and Methods. Blank values (250--500 dpm/60 min/ mg protein) were subtracted . T he 
data are the mean of triplicate measurements. 
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been shown to be closely linked to ano ther enzyme, vitamin K 
reductase. The latter enzy me is res ponsible fo r the reduction of 
vitamin K quinone to vitamin K hyd roquinone, which is an es-
sential cofactor in the ca rboxylation reaction. To detect the pres-
ence of vita min K redu ctase in dermis and epiderm is, in vitro 
ca rboxylation studies were perfo rm ed w ith vitamin K quinone 
as a cofactor instead of vitamin K hyd roquinone. T he carboxy-
lation rates were about 50% of the vitamin K hydroq uinone-
stimulated reaction fo r dermis and epidermis as w ell as fo r to tal 
skin microsomes. This is comparable w ith previous results found 
in bovine liver microsomes. In ad dition, the in vit ro inhibition 
by wa rfa rin of vitamin K quinone red uctase was measured . T he 
ca rboxylati on was ca rried out w ith vitamin K quinone as a co-
fac tor and at various warfarin concentra tions. In all microsomal 
preparations, a wa rfa rin concentra tion of 0.002 /LM inhi bi ted the 
ca rboxylation rate by 50% . From these results we concluded that 
vitamin K reductase is present in both derm al and epidermal 
microsomes. 
DISC U SS IO N 
It has been well established that the vi ta min K-dependent ca r-
boxylation reaction is not restricted to the li ver, but that it occurs 
in many nonhepatic tissues as well [6,7). In a previous study we 
have also demonstrated that the vitamin K-dependent carboxy-
lases from bovine liver, kidney, lung, and testis may be regarded 
as a group of isoenzy mes, w hich mainly differ in their substrate 
specific ity (1 8). In the present paper we report the discovery of 
vitamin K-dependent carboxylase in skin and , as in o ther tissues, 
the enzy me is loca ted in the microsomal frac ti on of tissue ho-
mogenates . It remains to be inves tiga ted w hether skin ca rboxylase 
is identi ca l with one of the prev iously discovered ca rboxylases or 
whether it is another distinct member of the group of vitamin 
K-dependent ca rboxy lases. 
The Cia residues which are fo rllled in the carboxylation reaction 
are known to bind strongly and selecti vely to Ca + + . T he Gla-
containing proteins discovered to date Illay be classified as fo ll ows 
[2): (1) the C Ia pro teins in blood plas ma (e.g., va ri ous coagulation 
fac tors), which are all able to bind to phos pho li pid surfaces via 
the complexed Ca + + ; (2) the C ia pro teins fo und in depos itions 
of insoluble calcium salts such as bone, dentin , renal stones, and 
atheromatous plaques; (3) the membrane-bound CIa pro teins, 
examples of w hich are fo und in the ki dney and in the chorioal-
lantoic membrane o f chicken eggs; and (4) the proteins that do 
not fit into one of the 3 fo rmer groups, such as a snail neurotoxin 
[1 9) and the Gla protein in sperm atozoa. Whereas mos t of the 
CIa proteins fo und in plasma are in volved in the process of blood 
coagulation, the fun ction of the o ther proteins is less clea r at this 
moment. 
In an attempt to estimate the physiologic importance of skin 
carboxylase, we have tried to identify its putative product. O b-
viously, this should be a C Ia-containing pro tein and we have tried 
to find such a protein in KO H extracts of hair and nail , in swea t, 
and in no rmal human and animal skin homogenates . In none of 
these produ cts could C ia be detected . However, skin ho moge-
nates, like liver ho mogenates, contain too many pro teins to detect 
C Ia without further puri fica tion . O n the o ther hand , a C ia- con-
taining protein has been reported to occur in the pathologic dep-
ositions of calcified material in the skin of patients sufferin g fro m 
scleroderm a and dermatom yositi s [1 2). O bviously the latter pro-
tein belongs to the ca tego ry mentioned under (2) (see above) , but 
whether it is indeed produced by skin ca rboxylase is not certain 
at this moment. 
Specul ating about the function of the skin C ia protein we would 
like to mention 2 possibili ties . In the fi rst place the pro tein might 
playa role in the calcium metabolism in skin . Indi ca tions in favor 
of this hypothesis were obtained from clinical studies in w hich 
patients with dermatomyosit is and massive depositions of sub-
cutaneous calcific nodules were treated with low doses of war-
farin. This trea tment induced a profound and rapid decrease of 
the calcified lesions (20). As wa rfar in inhibits the formation of 
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Gla, these data suggest a possible role for the skin Gla protein in 
the regulation of the calcifica tion process. 
Alternatively, a pathologic effect of warfarin on skin has been 
described: especially during the ea rly stages of oral anticoagulant 
treatment skin necrosis may occur (21). It has been proposed that 
the latter phenomenon may be the result of an increased throm-
bogenic activity in the capillaries induced by a protein C defi-
ciency (22) . Protein C is a Gla-containing plasma protein, produced 
by the liver and indeed it has an anticoagulant activity [23) . With-
out doubt its synthesis is inhibited by warfarin. It is remarkable, 
however, that the disturbed balance between protein C and the 
vitamin K-dependent coagulation factors has been reported to 
cause ischemic necrosis of capillaries in skin on ly and not in other 
tissues. T herefore another protein may also be involved in the 
occurrence of this type of thrombosis. Such a protein might be 
the putative skin Gla protein which is produced by skin carbox-
ylase. In this paper we have shown that coumarin derivatives 
directly inhibit skin carboxylase and thus the carboxylation of the 
skin Gla protein . T his might result in a decresaed biologic activity 
of the latter, which may play an add itional role in the observed 
skin necrosis. 
Obviously further research is wanted to elucidate the function 
of the skin Gla protein and thus the physiologic importance of 
the vitamin K-dependent skin carboxylase . 
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